Suchergebnisse - (Standardsuche:issn:"1354-3784" OR issn:"1744-7658")

PubPharm (78)

71

Investigational drugs for treating anal cancer and future perspectives

enthalten in: Expert opinion on investigational drugs | 2016

von Bustamante, L. | Frakes, J. | Hoffe, S. | +1

72

The potential of neurotrophic tyrosine kinase (NTRK) inhibitors for treating lung cancer

enthalten in: Expert opinion on investigational drugs | 2016

von Passiglia, F. | Caparica, R. | Giovannetti, E. | +8

73

Phase II clinical trials on investigational drugs for the treatment of pancreatic cancers

enthalten in: Expert opinion on investigational drugs | 2015

von Kim, E. | Semrad, T. | Bold, R.

74

Investigational selectin-targeted therapy of sickle cell disease

enthalten in: Expert opinion on investigational drugs | 2015

von Okpala, I.

75

An overview of early investigational therapies for chemoresistant ovarian cancer

enthalten in: Expert opinion on investigational drugs | 2015

von Marchetti, C. | Ledermann, J. | Benedetti Panici, P.

76

Beyond standard therapy : drugs under investigation for the treatment of gastrointestinal stromal tumor

enthalten in: Expert opinion on investigational drugs | 2015

von Alturkmani, H. | Pessetto, Z. | Godwin, A.

77

Targeted therapy and promising novel agents for the treatment of advanced soft tissue sarcomas

enthalten in: Expert opinion on investigational drugs | 2015

von Mohindra, N. | Agulnik, M.

78

Modulators of the urokinase-type plasminogen activation system for cancer

enthalten in: Expert opinion on investigational drugs | 19 Apr 2010

von Hildenbrand, R. | Allgayer, H. | Marx, A. | +1

[1]
« Vorheriger
1
2
3
4
5
6
7
8